Skip to content
OpenCapital
Get started

OptimizeRx OPRX Market capitalization

Market capitalization at other companies

Veeva Systems logo
Veeva SystemsVEEV
$25.47B-31.2%
Phreesia logo
PhreesiaPHR
$559.63M-61.3%
Doximity logo
DoximityDOCS
$4.3B-60.5%
GoodRx Holdings, Inc. logo
GoodRx Holdings, Inc.GDRX
$671.45M-60.3%
PubMatic logo
PubMaticPUBM
$387.78M-12.6%
National Research Corporation logo
National Research CorporationNRC
$386.23M+31.5%

Other financials

Income statement

See full
Revenue$19.8M-9.5%
Gross profit$14.9M+11.9%
Operating income$396.0K+119%
Net income-$495.0K+77.5%
EPS (diluted)-$0.03+75.0%

Balance sheet

See full
Cash & equivalents$20.2M+21.7%
Total debt$23.7M-27.7%
Total equity$129.6M+11.5%
Total assets$167.3M-0.3%

Cash flow

See full
Operating cash flow-$467.0K-112%
CapEx$21.0K-22.2%
Free cash flow-$488.0K-113%

Valuation

See full
Enterprise value$110.88M-55.0%
P/E15.7×—
P/S1×-1.2×

Profitability

See full
Gross margin70%+14.1pp
Operating margin13.2%—
Net margin6.4%+3.6pp
FCF margin13.4%+4.8pp

Returns & leverage

See full
Return on equity5.6%+3.3pp
Debt / equity0.2×-0.1×
Current ratio5.4×+2.6×

Where this comes from

Computed from the period-end share price: $117.83M.

The official record: OptimizeRx’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about OptimizeRx's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OptimizeRx's market capitalization?
OptimizeRx (OPRX) reported market capitalization of $117.83M in Q1 2026.
How has OptimizeRx's market capitalization changed year-over-year?
OptimizeRx's market capitalization decreased by 26.4% year-over-year, from $160.13M to $117.83M.
What is the long-term trend for OptimizeRx's market capitalization?
Over 5 years (2020 to 2025), OptimizeRx's market capitalization has grown at a -16.2% compound annual growth rate (CAGR), from $553.7M to $228.53M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.